SCHEMBL4667545

SCHEMBL4667545

NC(=O)OCCCN1CC2CN(Cc3ccccc3)CC(C1)O2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
S1PR5 Q9H228 4/20 0.42
S1PR1 P21453 2/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
SLC29A1 Q99808 1/20 0.41
FUCA1 P04066 2/20 0.40
MAPK1 P28482 1/20 0.40
MAOB P27338 2/20 0.39
SIRT1 Q96EB6 1/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA4 P22748 2/20 0.38
CA9 Q16790 2/20 0.38
DRD3 P35462 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
BCHE P06276 2/20 0.38
ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28737418 0.82 LMNA (0.56) LMNAKDM4EALDH1A1SLC29A1MAOB
SCHEMBL5622214 0.81 KMT2A (0.47) S1PR5S1PR1KDM4EALDH1A1FUCA1
SCHEMBL4670377 0.78 ALDH1A1 (0.48) S1PR5S1PR1ALDH1A1POLBFUCA1
SCHEMBL3315165 0.76 FUCA1 (0.51) S1PR5S1PR1ALDH1A1FUCA1
SCHEMBL4669376 0.75 HRH3 (0.33) LMNAKDM4EALDH1A1POLBHRH3
SCHEMBL2968146 0.74 S1PR5 (0.51) LMNAS1PR5S1PR1KDM4EALDH1A1
SCHEMBL5072489 0.74 SIGMAR1 (0.47) S1PR5S1PR1POLBFUCA1CA1
SCHEMBL5316198 0.74 DRD4 (0.50) S1PR5S1PR1FUCA1ACHE
Hydrochloric Acid SCHEMBL2966846 0.73 S1PR5 (0.50) LMNAS1PR5S1PR1KDM4EALDH1A1
SCHEMBL28737370 0.73 KMT2A (0.57) LMNAKDM4EALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893619-A1 NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTMIAS AstraZeneca AB (SE) 2008-03-05 EP disclosed
WO-2006135316-A1 New oxabispidine compounds for the treatment of cardiac arrhythmias ASTRAZENECA AB (SE) 2006-12-21 WO disclosed